BridgeMD
Tests treatment safety and results for Menopause
Official title Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Women
ClinicalTrials.gov ID: NCT06710002
What this study is testing
- What it's testing
- The aim of this study is to analyze the effectiveness of a telerehabilitation program with respect to a face-to-face physiotherapy protocol in relation to the improvement of sexual function, the reduction of pain and the improvement of the quality of life, in the treatment of menopausal women with dyspareunia.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 65, women only
You may be able to join if
- Female
- Age from 45 to 65 years.
- Menopausal
- Suffer dyspareunia for 3 months of evolution.
- Willing to complete study questionnaires and informed consent study.
You likely can't join if
- Pacemaker or other types of electronic implant.
- Thrombophlebitis.
- Skin hypersensitivity or rejection of manual contact.
- Active or previous treatment with chemotherapy or radiotherapy in the pelvic area.
- Wounds or burns in the pelvic area.
- Allergy to nickel and chromium.
See the full eligibility criteria
- Female
- Age from 45 to 65 years.
- Menopausal
- Suffer dyspareunia for 3 months of evolution.
- Willing to complete study questionnaires and informed consent study.
- Pacemaker or other types of electronic implant.
- Thrombophlebitis.
- Skin hypersensitivity or rejection of manual contact.
- Active or previous treatment with chemotherapy or radiotherapy in the pelvic area.
- Wounds or burns in the pelvic area.
- Allergy to nickel and chromium.
- Other pelvic floor physiotherapy treatments during the study intervention.
- Other medical and surgical treatments in the pelvic region, such as muscle infiltrations or nerve blocks during the study intervention.
- Surgical intervention in the pelvic area in the last 3 months.
- Fibromyalgia.
- Oncological processes that affect the sacrum.
- Systemic diseases (infectious, vascular, endocrine, metabolic or neoplastic conditions).
- Neuromuscular diseases (Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Myasthenia Gravis or spinal muscular atrophy).
- Myelopathy and Osteomyelitis.
- Diseases that cause alterations of the central nervous system (traumatic or vascular spinal cord injury).
- Neurological or metabolic conditions that affect the ability to respond (Diabetes, Parkinson's disease, senile dementia, etc).
- Serious mental disorder.
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Spain, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 45 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Spain, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.